CN113713068A - Foot bath powder capable of tonifying spleen, eliminating dampness, promoting blood circulation and soothing nerves - Google Patents
Foot bath powder capable of tonifying spleen, eliminating dampness, promoting blood circulation and soothing nerves Download PDFInfo
- Publication number
- CN113713068A CN113713068A CN202111079752.8A CN202111079752A CN113713068A CN 113713068 A CN113713068 A CN 113713068A CN 202111079752 A CN202111079752 A CN 202111079752A CN 113713068 A CN113713068 A CN 113713068A
- Authority
- CN
- China
- Prior art keywords
- parts
- raw
- servings
- spleen
- blood circulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000952 spleen Anatomy 0.000 title claims abstract description 27
- 239000000843 powder Substances 0.000 title claims abstract description 13
- 230000017531 blood circulation Effects 0.000 title claims abstract description 12
- 210000005036 nerve Anatomy 0.000 title claims abstract description 12
- 230000001737 promoting effect Effects 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 26
- 229940079593 drug Drugs 0.000 claims abstract description 9
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 7
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 7
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract 4
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract 4
- 210000002683 foot Anatomy 0.000 claims description 19
- 241000132012 Atractylodes Species 0.000 claims description 12
- 244000020518 Carthamus tinctorius Species 0.000 claims description 9
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 8
- 235000006533 astragalus Nutrition 0.000 claims description 7
- 235000010894 Artemisia argyi Nutrition 0.000 claims description 6
- 241001061264 Astragalus Species 0.000 claims description 6
- 240000002943 Elettaria cardamomum Species 0.000 claims description 6
- 235000005300 cardamomo Nutrition 0.000 claims description 6
- 210000004233 talus Anatomy 0.000 claims description 6
- 244000089698 Zanthoxylum simulans Species 0.000 claims description 5
- 235000011438 Albizia odoratissima Nutrition 0.000 claims description 4
- 235000017276 Salvia Nutrition 0.000 claims description 3
- 240000007164 Salvia officinalis Species 0.000 claims description 2
- 241001435059 Artemisia argyi Species 0.000 claims 3
- 239000008669 duhuo Substances 0.000 claims 3
- 238000005728 strengthening Methods 0.000 claims 3
- 240000007472 Leucaena leucocephala Species 0.000 claims 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 claims 2
- 241000208966 Polygala Species 0.000 claims 2
- 230000000422 nocturnal effect Effects 0.000 claims 2
- 240000000559 Albizia odoratissima Species 0.000 claims 1
- 241001638289 Polygala japonica Species 0.000 claims 1
- 244000184734 Pyrus japonica Species 0.000 claims 1
- 241001072909 Salvia Species 0.000 claims 1
- 235000009932 Zanthoxylum simulans Nutrition 0.000 claims 1
- 208000007882 Gastritis Diseases 0.000 abstract description 23
- 208000023652 chronic gastritis Diseases 0.000 abstract description 17
- 201000010099 disease Diseases 0.000 abstract description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 13
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 12
- 206010022437 insomnia Diseases 0.000 abstract description 12
- 208000024891 symptom Diseases 0.000 abstract description 7
- 230000008506 pathogenesis Effects 0.000 abstract description 4
- 208000019901 Anxiety disease Diseases 0.000 abstract description 3
- 208000007443 Neurasthenia Diseases 0.000 abstract description 3
- 230000036506 anxiety Effects 0.000 abstract description 3
- 206010003549 asthenia Diseases 0.000 abstract description 3
- 206010009887 colitis Diseases 0.000 abstract description 2
- 201000006549 dyspepsia Diseases 0.000 abstract description 2
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 210000004185 liver Anatomy 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000002994 raw material Substances 0.000 description 7
- 230000003860 sleep quality Effects 0.000 description 7
- 241000222336 Ganoderma Species 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 241001080798 Polygala tenuifolia Species 0.000 description 5
- 240000001341 Reynoutria japonica Species 0.000 description 5
- 235000018167 Reynoutria japonica Nutrition 0.000 description 5
- 230000003213 activating effect Effects 0.000 description 5
- 230000002936 tranquilizing effect Effects 0.000 description 5
- 235000002566 Capsicum Nutrition 0.000 description 4
- 241000735527 Eupatorium Species 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 239000006002 Pepper Substances 0.000 description 4
- 241000722363 Piper Species 0.000 description 4
- 235000016761 Piper aduncum Nutrition 0.000 description 4
- 235000017804 Piper guineense Nutrition 0.000 description 4
- 235000008184 Piper nigrum Nutrition 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 241000220433 Albizia Species 0.000 description 3
- 244000030166 artemisia Species 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 240000007185 Albizia julibrissin Species 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 230000004622 sleep time Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000002618 waking effect Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 235000011468 Albizia julibrissin Nutrition 0.000 description 1
- 244000059800 Amomum compactum Species 0.000 description 1
- 235000016426 Amomum compactum Nutrition 0.000 description 1
- 241001254604 Angelica pubescens Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- 238000012327 Endoscopic diagnosis Methods 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- 241000146384 Glaux Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019375 Helicobacter infections Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 244000116484 Inula helenium Species 0.000 description 1
- 235000002598 Inula helenium Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 208000015864 chronic erosive gastritis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004620 sleep latency Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Anesthesiology (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开一种健脾祛湿活血安神足浴粉，其由生白术、生黄芪、白豆蔻、佩兰、苍术、艾叶、独活、木香、红花、花椒、远志、夜交藤、合欢花、丹参、灵芝、生龙骨组成，本方中根据慢性胃炎病机及其失眠的病机，各药协同作用，从多方位对慢性胃炎、慢性胃炎所引起的失眠及其伴有的焦虑、抑郁、神疲乏力、神经衰弱等进行治疗，标本兼治，并且本发明还可对功能性消化不良、结肠炎、肠易激综合征等症进行治疗。The invention discloses a foot bath powder for invigorating the spleen, removing dampness, promoting blood circulation and soothing the nerves. It is composed of Salvia miltiorrhiza, Ganoderma lucidum, and raw keel. According to the pathogenesis of chronic gastritis and its insomnia, each drug has a synergistic effect to treat chronic gastritis, insomnia caused by chronic gastritis and its accompanying anxiety, depression, Shenpi fatigue, neurasthenia and the like can be treated, both the symptoms and root causes can be treated, and the present invention can also treat functional dyspepsia, colitis, irritable bowel syndrome and other diseases.
Description
Technical Field
The invention relates to the technical field of medicines, and in particular relates to a foot bath powder capable of tonifying spleen, eliminating dampness, promoting blood circulation and soothing nerves.
Background
Chronic gastritis is a digestive system disease with a high incidence rate. The disease has the characteristics of long course of disease, high incidence rate, easy repeated attack and the like. Clinically, chronic gastritis is classified into superficial gastritis, chronic erosive gastritis and chronic atrophic gastritis, and the incidence of the gastritis is mostly related to helicobacter pylori infection, virus or irritant substance factors. The traditional Chinese medicine considers that the disease is related to a plurality of factors such as living environment, mental state, eating habits and the like, which are often manifested as vague pain in the upper abdomen, anorexia, postprandial fullness, acid regurgitation, hematemesis, dark stool and the like, besides, part of patients with chronic gastritis are even accompanied with insomnia, and frequent insomnia causes the reduction of sleep quality, memory and attention of the patients, and also can cause diseases such as depression, anxiety, neurasthenia, climacteric syndrome and the like.
Disclosure of Invention
Therefore, based on the background, the invention aims to provide the foot bath powder for tonifying spleen, clearing damp, activating blood circulation and calming the nerves, which can treat chronic gastritis and complications such as insomnia caused by the chronic gastritis from multiple directions, and can be absorbed and administered through skin in a foot bath powder form, so that the stimulation influence of the medicine on intestines and stomach can be avoided, the effective components of the medicine can quickly reach the whole body through blood circulation through liquid medicine, and the medicine effect is ensured.
The traditional Chinese medicine considers that five zang organs and six fu organs of a human body have corresponding physiological reflecting regions on soles, more than 60 acupuncture points are arranged on the feet, and 47 individual physiological reflecting regions are arranged on the feet. The feet are the starting points of the three yin channels of the feet (spleen channel, liver channel and kidney channel) and the termination points of the three yang channels of the feet (stomach channel, gallbladder channel and bladder channel), so the feet can stimulate the acupuncture points, reflecting areas and meridians of the feet by bathing the feet to treat diseases.
The technical scheme provided by the invention is as follows:
a foot bath powder for invigorating spleen, eliminating dampness, promoting blood circulation and calming nerves is prepared from the following raw material medicines:
raw white atractylodes rhizome, raw astragalus, round cardamom, fortune eupatorium herb, swordlike atractylodes rhizome, Chinese mugwort leaf, doubleteeth pubescent angelica root, costustoot, safflower, Chinese prickly ash, thinleaf milkwort root-bark, tuber fleeceflower stem, silktree albizzia flower, red-rooted salvia root, lucid ganoderma and raw dragon bone.
Further, the traditional Chinese medicine composition comprises the following raw material medicines in parts by weight:
10-40 parts of raw bighead atractylodes rhizome, 10-40 parts of raw astragalus membranaceus, 10-40 parts of amomum cardamomum, 10-40 parts of fortune eupatorium herb, 20-50 parts of rhizoma atractylodis, 10-40 parts of folium artemisiae argyi, 10-40 parts of radix angelicae pubescentis, 10-40 parts of elecampane, 5-40 parts of safflower carthamus, 10-40 parts of pepper, 10-40 parts of polygala tenuifolia, 10-40 parts of tuber fleeceflower stem, 10-40 parts of flos albiziae, 10-40 parts of salvia miltiorrhiza, 10-40 parts of lucid ganoderma and 10-40 parts of raw keel.
Further, the traditional Chinese medicine composition comprises the following raw material medicines in parts by weight:
30 parts of raw bighead atractylodes rhizome, 30 parts of raw astragalus, 30 parts of amomum cardamomum, 30 parts of fortune eupatorium herb, 40 parts of rhizoma atractylodis, 30 parts of Chinese mugwort leaf, 30 parts of radix angelicae pubescentis, 30 parts of costustoot, 20 parts of safflower, 30 parts of pepper, 30 parts of polygala tenuifolia, 30 parts of tuber fleeceflower stem, 30 parts of albizia flower, 30 parts of salvia miltiorrhiza, 30 parts of lucid ganoderma and 30 parts of raw keel.
In the raw materials used in the formula, the white atractylodes rhizome enters spleen and stomach channels, strengthens spleen and tonifies qi, eliminates dampness and promotes diuresis; astragalus root, radix astragali, entering lung, spleen channel, invigorating qi and consolidating superficial resistance, inducing diuresis and expelling toxin; fructus Amomi rotundus, entering lung, spleen and stomach channels, eliminating dampness and relieving oppression, activating qi-flowing and warming middle energizer, and promoting appetite and digestion; herba Eupatorii, having effects in invigorating spleen, stomach and lung channels, eliminating dampness with aromatics, activating spleen, stimulating appetite, relieving exterior syndrome, and clearing summer-heat; rhizoma Atractylodis, which belongs to spleen, stomach and liver channels, can eliminate dampness, invigorate spleen, expel wind and cold, and improve eyesight; folium artemisiae argyi, which belongs to liver, spleen and kidney channels, dispels cold to relieve pain, warms channel to stop bleeding; radix Angelicae Pubescentis, entering kidney and bladder channels, dispelling pathogenic wind and removing dampness, relieving arthralgia and relieving pain; radix aucklandiae, which is responsible for spleen, stomach, large intestine, triple energizer and gallbladder channel, and has effects of promoting qi circulation, relieving pain, invigorating spleen and promoting digestion; safflower, which enters heart and liver meridians, promotes blood circulation to remove meridian obstruction, removes blood stasis and relieves pain; the Chinese prickly ash, which belongs to spleen, lung and kidney channels, warms middle-jiao to dispel cold, dehumidifies and relieves pain; polygala tenuifolia, radix Polygalae, heart, kidney and lung channels, tranquilizing mind, improving intelligence, and eliminating phlegm; caulis Polygoni Multiflori, which enters heart and liver channels, has effects of nourishing blood, tranquilizing mind, dispelling pathogenic wind, and dredging collaterals; albizia julibrissin, which enters heart and liver meridians, relieves depression and soothes nerves; the salvia miltiorrhiza, which belongs to heart and liver channels, removes stasis and relieves pain, activates blood and promotes menstruation, clears heart and relieves restlessness; the lucid ganoderma, which belongs to the liver, the lung and the kidney, can tonify qi, soothe nerves and relieve cough and asthma; raw Long Gu, entering heart, liver and kidney meridians, relieving convulsion and tranquilizing; pacify liver and subdue yang.
The chronic gastritis belongs to the category of epigastric pain and epigastric fullness in traditional Chinese medicine, and causes of diseases comprise improper diet, imbalance of cold and warm, emotional disorder, weakness of spleen and stomach and the like. Its pathogenesis can be summarized as stomach-qi disharmony, qi stagnation, dwarfing of collaterals, loss of coordination and descending, and pain caused by obstruction. Impairment of the spleen and stomach, phlegm-dampness, phlegm-heat, and phlegm-heat disturbing the heart-mind can cause insomnia.
Therefore, the traditional Chinese medicine composition can treat the chronic gastritis and insomnia caused by the chronic gastritis at the same time, and can treat both symptoms and root causes. According to the pathogenesis of chronic gastritis and the pathogenesis of insomnia, the raw rhizoma atractylodis macrocephalae and the rhizoma atractylodis are adopted to strengthen spleen and dry dampness; fructus Amomi rotundus and herba Eupatorii can eliminate dampness, and radix Angelicae Pubescentis can dredge channels and collaterals, ventilate blood, dispel wind and remove dampness; radix astragali has effects of invigorating qi and invigorating yang; for pain symptoms accompanied with chronic gastritis, folium artemisiae argyi and pepper are adopted for dispelling cold and relieving pain, and safflower and salvia miltiorrhiza are adopted for clearing and activating the channels and collaterals, activating blood, dissipating blood stasis and relieving pain; the traditional Chinese medicine composition is matched with polygala tenuifolia for tranquilizing and allaying excitement, tuber fleeceflower stem and lucid ganoderma are used for tranquilizing and allaying excitement, keel is used for relieving convulsion and allaying excitement, albizia flower is used for dispelling melancholy and allaying excitement, and the raw materials have synergistic effects, so that the traditional Chinese medicine composition has the effects of tonifying spleen and warming middle energizer, clearing damp and dispelling cold, nourishing heart and allaying excitement and the like, and can be used for treating insomnia caused by chronic gastritis and anxiety, depression, mental fatigue, hypodynamia, neurasthenia and the like accompanied by the insomnia, and the traditional Chinese medicine composition can also be used for treating symptoms such as functional dyspepsia, colitis, irritable bowel syndrome and the like.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are some embodiments of the present invention, but not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1: a foot bath powder capable of invigorating spleen, eliminating dampness, promoting blood circulation and calming nerves is composed of the following raw material medicines in parts by weight:
30 parts of raw bighead atractylodes rhizome, 30 parts of raw astragalus, 30 parts of amomum cardamomum, 30 parts of fortune eupatorium herb, 40 parts of rhizoma atractylodis, 30 parts of Chinese mugwort leaf, 30 parts of radix angelicae pubescentis, 30 parts of costustoot, 20 parts of safflower, 30 parts of pepper, 30 parts of polygala tenuifolia, 30 parts of tuber fleeceflower stem, 30 parts of albizia flower, 30 parts of salvia miltiorrhiza, 30 parts of lucid ganoderma and 30 parts of raw keel.
When in use, the raw materials are weighed according to the amount, mixed, made into powder, sieved by a sieve of 80-100 meshes and subpackaged according to 15 g/bag.
The use method comprises the following steps: soaking in warm boiled water (more than 3000 ml) for 30-40 min for 1 bag per time 1 time per day.
Example 2: clinical curative effect
Selecting 230 patients diagnosed with chronic gastritis accompanied with insomnia in subsidiary hospitals of Shanxi Chinese medicine university from 1 month to 2021 month in 2019, wherein 108 patients are male, and 122 patients are female; the minimum age is 20 years, the maximum age is 75 years, and the average age is 63.87 years; the shortest disease course is 3 months, the longest disease course is 20 years, and the average disease course is 7.9 years.
1) Diagnosis standard of chronic gastritis: the Chinese medicine preparation meets the diagnosis standard of Chinese consensus on chronic gastritis (2017, Shanghai):
carrying out endoscopic diagnosis: according to the pathological changes of mucous membrane under endoscope, it can be divided into two categories of chronic atrophic gastritis and chronic non-atrophic gastritis (i.e. chronic superficial gastritis).
Pathological and histological diagnosis: mainly, chronic inflammatory cell (mononuclear cell) infiltration is taken as a main component, and lymphocytes and plasma cells are mainly taken as main components.
2) Diagnostic criteria for insomnia:
firstly, difficulty in falling asleep: the sleep latency time is prolonged and is longer than 30 min;
② uneasy sleep: the awakening time is increased, and the time is more than 30min every night; the actual sleep time is reduced, and is less than 6.5 hours per night; the wake time accounts for more than 10% of the sleep time;
③ waking up early: the sleep wake-up time is 30min earlier than the normal wake-up time of the plain;
fourthly, the user does not have recovery feeling after waking up, is sleepy in the daytime, does not concentrate on attention or has dysmnesia, and influences learning and working.
3) The case inclusion standard is that the case inclusion standard accords with a diagnosis standard;
② 18-78 years old;
③ patients without serious systemic diseases of heart, liver and kidney;
fourthly, the patients and the family members know the information and sign an informed consent.
4) Case exclusion criteria:
firstly, in the acute attack stage of the disease;
refusing to accept the traditional Chinese medicine external treatment;
③ organic diseases of organs such as heart, liver and kidney which are serious;
fourthly, the mental disease or the blood coagulation dysfunction is combined;
fifthly, the traditional Chinese medicine foot bath therapy cannot be borne.
5) Criteria for treatment evaluation
The effect is shown: the gastritis symptom of the patient completely disappears, and the sleep quality is greatly improved;
the method has the following advantages: the gastritis symptom of a patient is relieved, and the sleep quality is improved;
and (4) invalidation: the gastritis symptoms of the patients are not improved at all or even more seriously, and the sleep quality is not improved at all. Wherein the sleep quality before and after treatment of the patient is evaluated by a Pittsburgh Sleep Quality Index (PSQI) scale, and the higher the PSQI score is, the worse the sleep quality of the patient is.
6) The traditional Chinese medicine foot bath powder in the embodiment 1 is used for treating 3 treatment courses, 1 treatment course is 4 weeks, and the results show that 102 cases are effective, the proportion is 44.35%, 111 cases are effective, the proportion is 48.26%, 17 cases are ineffective, the proportion is 7.39%, and the total effective rate is 92.61%.
The present invention and the embodiments thereof have been described above, but the description is not limited thereto, and the embodiment shown is only one of the embodiments of the present invention, and the actual structure is not limited thereto. In summary, those skilled in the art should appreciate that they can readily use the disclosed conception and specific embodiments as a basis for designing or modifying other structures for carrying out the same purposes of the present invention without departing from the spirit and scope of the invention as defined by the appended claims.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111079752.8A CN113713068B (en) | 2021-09-15 | 2021-09-15 | Foot bath powder capable of tonifying spleen, eliminating dampness, promoting blood circulation and soothing nerves |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111079752.8A CN113713068B (en) | 2021-09-15 | 2021-09-15 | Foot bath powder capable of tonifying spleen, eliminating dampness, promoting blood circulation and soothing nerves |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113713068A true CN113713068A (en) | 2021-11-30 |
| CN113713068B CN113713068B (en) | 2022-12-06 |
Family
ID=78683861
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111079752.8A Active CN113713068B (en) | 2021-09-15 | 2021-09-15 | Foot bath powder capable of tonifying spleen, eliminating dampness, promoting blood circulation and soothing nerves |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113713068B (en) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101607029A (en) * | 2008-06-22 | 2009-12-23 | 董宪常 | Method for treating insomnia by soaking feet with traditional Chinese medicines |
| CN104623536A (en) * | 2015-01-15 | 2015-05-20 | 刘昌红 | Chinese medicinal combination for treating insomnia |
| CN105708901A (en) * | 2016-03-29 | 2016-06-29 | 杜艳茹 | Foot-bath medicine for treating turbid toxin accumulation type chronic atrophic gastritis and preparation method of foot-bath medicine |
| CN105963505A (en) * | 2016-05-05 | 2016-09-28 | 刘秀梅 | Traditional Chinese medicinal foot bath powder capable of treating insomnia |
| WO2017181988A1 (en) * | 2016-04-21 | 2017-10-26 | 张东 | Traditional-chinese-medicine composition effective in treating various conditions, and derivative thereof and product thereof |
| CN107596312A (en) * | 2017-09-28 | 2018-01-19 | 湖南省大豪药业有限责任公司科技发展中心 | A kind of Chinese medicine pedicure bag with auxiliary treatment effect and preparation method thereof |
| CN109010785A (en) * | 2018-11-01 | 2018-12-18 | 长江大学 | A kind of traditional Chinese medicine pill for treating chronic gastritis and gastric ulcer |
| CN112516230A (en) * | 2020-12-28 | 2021-03-19 | 河北省中医院 | Traditional Chinese medicine composition for foot bath for treating epigastric pain and insomnia and preparation method and application thereof |
-
2021
- 2021-09-15 CN CN202111079752.8A patent/CN113713068B/en active Active
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101607029A (en) * | 2008-06-22 | 2009-12-23 | 董宪常 | Method for treating insomnia by soaking feet with traditional Chinese medicines |
| CN104623536A (en) * | 2015-01-15 | 2015-05-20 | 刘昌红 | Chinese medicinal combination for treating insomnia |
| CN105708901A (en) * | 2016-03-29 | 2016-06-29 | 杜艳茹 | Foot-bath medicine for treating turbid toxin accumulation type chronic atrophic gastritis and preparation method of foot-bath medicine |
| WO2017181988A1 (en) * | 2016-04-21 | 2017-10-26 | 张东 | Traditional-chinese-medicine composition effective in treating various conditions, and derivative thereof and product thereof |
| CN105963505A (en) * | 2016-05-05 | 2016-09-28 | 刘秀梅 | Traditional Chinese medicinal foot bath powder capable of treating insomnia |
| CN107596312A (en) * | 2017-09-28 | 2018-01-19 | 湖南省大豪药业有限责任公司科技发展中心 | A kind of Chinese medicine pedicure bag with auxiliary treatment effect and preparation method thereof |
| CN109010785A (en) * | 2018-11-01 | 2018-12-18 | 长江大学 | A kind of traditional Chinese medicine pill for treating chronic gastritis and gastric ulcer |
| CN112516230A (en) * | 2020-12-28 | 2021-03-19 | 河北省中医院 | Traditional Chinese medicine composition for foot bath for treating epigastric pain and insomnia and preparation method and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| 王高峰等: "单兆伟治疗慢性萎缩性胃炎合并失眠的经验", 《广西中医药》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113713068B (en) | 2022-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102247585A (en) | Chinese medicinal composition for treating rheumatism, preparation thereof and preparation method thereof | |
| CN101244195B (en) | Medicament for treating aypnia | |
| CN104491759A (en) | Traditional Chinese medicine composition for treating cephalagra and preparation method thereof | |
| CN108030864A (en) | A kind of strong medicine liquid for treating traumatic injury, burn and inflammation | |
| CN104524337A (en) | Traditional Chinese medicine for treating dental ulcer | |
| CN102198203A (en) | Traditional Chinese medicine for treating nonalcoholic fatty liver diseases | |
| CN100457158C (en) | Medicine for fortifying human body immune function | |
| CN104415195A (en) | Meridian toxin eliminating paste for subhealth conditioning, and preparation method thereof | |
| CN104173957A (en) | Anti-senile life-prolonging plaster | |
| CN102579799B (en) | Traditional Chinese medicine composition for treating postpartum fever with blood deficiency | |
| CN1321669C (en) | Chinese herbal medicine for treating urticaria | |
| CN104353051A (en) | Traditional Chinese medicine preparation for treating stomachache and preparation method thereof | |
| CN104324350A (en) | Traditional Chinese medicine composition for chronic colitis and preparation method of traditional Chinese medicine composition | |
| CN105125792A (en) | Traditional Chinese medicinal decoction for treating female mastitis and preparation method of decoction | |
| CN104826012A (en) | Traditional Chinese medicine preparation for pituitary tumor surgery postoperative nursing and preparation method thereof | |
| CN113713068A (en) | Foot bath powder capable of tonifying spleen, eliminating dampness, promoting blood circulation and soothing nerves | |
| CN203252935U (en) | Anti-senile and life-prolonging plaster | |
| CN104606600A (en) | Traditional Chinese medicine composition for treating interstitial lung disease and preparation method of composition | |
| CN104623532A (en) | Traditional Chinese medicine composition for treating glioma and preparation method thereof | |
| CN104524535A (en) | Traditional Chinese medicine composition for treating chronic pulmonary heart disease and preparation method of traditional Chinese medicine composition | |
| CN1342478A (en) | Medical wine for treating rheumatism | |
| CN102357210B (en) | Traditional Chinese medicine composition for curing facial acne | |
| CN104740332A (en) | Traditional Chinese medicine used for treating erythema nodosum | |
| CN102698102A (en) | Traditional Chinese medicament for treating chronic laryngitis | |
| CN106177572A (en) | A kind of Chinese medicine decoction treating aplastic anemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20250213 Address after: 518110 2402, Block A, Phase A, Longguang Jiuzuan North, Daling Community, Minzhi Street, Longhua District, Shenzhen City, Guangdong Province Patentee after: Shenzhen Mingyu Information Technology Co.,Ltd. Country or region after: China Address before: 712000 Xianyang city of Shaanxi province Weiyang Road No. 1 Patentee before: SHAANXI University OF CHINESE MEDICINE Country or region before: China |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20250217 Address after: Room 1006-1, No. 48 Hanxing Middle Road, Zhongcun Street, Panyu District, Guangzhou City, Guangdong Province 510000 Patentee after: Guangzhou Yuze Investment Co.,Ltd. Country or region after: China Address before: 518110 2402, Block A, Phase A, Longguang Jiuzuan North, Daling Community, Minzhi Street, Longhua District, Shenzhen City, Guangdong Province Patentee before: Shenzhen Mingyu Information Technology Co.,Ltd. Country or region before: China |
|
| TR01 | Transfer of patent right |